Nader Oskooilar
Psychiatry · Newport Beach, CANPI 1336144872
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 36 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by AbbVie at 56.4% of the total.
Across 36 payments — averaging $23.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$474
- Adlon Therapeutics L.p.$143
- Neuronetics, Inc.$137
- Sunovion Pharmaceuticals Inc.$41
- Vanda Pharmaceuticals Inc.$27
- Johnson & Johnson$18
Across 749 payments — averaging $4449.11 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$815K
- Eli Lilly$444K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$275K
- Supernus Pharmaceuticals, Inc.$246K
- Pfizer$246K
- Genentech, Inc.$229K
- plus $1.1M from 10 others
What the payments were for
- Food & beverage$840100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 20 | $474 |
| Adlon Therapeutics L.p. | 8 | $143 |
| Neuronetics, Inc. | 2 | $137 |
| Sunovion Pharmaceuticals Inc. | 4 | $41 |
| Vanda Pharmaceuticals Inc. | 1 | $27 |
| Johnson & Johnson | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$125
How this compares
$840 in reported general payments places this provider in the 70th percentile of 4,954 psychiatry providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Paroxetine ErParoxetine Hcl | 11 | $795 |
| Methylphenidate Hcl | 18 | $776 |
| Olanzapine | 22 | $337 |
| Escitalopram Oxalate | 14 | $132 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Newport Beach
- Gustavo AlvaOrange$5.8M
- John KooSan Francisco$3M
- Jason KelloggIrvine$2.7M
- Jonathan MeyerSan Diego$2.3M
- Charles Tuan-Tu NguyenIrvine$2.1M
- Manoj WaikarLos Gatos$1.9M
- Gerald MaguireSan Juan Capistraco$1.8M
- Salima BrillmanSunnyvale$1.4M
- Bibi DasStanford$1.4M
- Konstantinos TripodisBurbank$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.